Half-year Report ended 30 June 2023

Rothschild & Co Contin Fin CI Ltd
04 September 2023
 

Rothschild & Co Continuation Finance CI Limited

 

Half-yearly Report for the six-month period ended 30 June 2023

 

Interim Management Report

 

Summary of Important Events

 

Rothschild & Co Continuation Finance CI Limited (the "Company") is a wholly-owned subsidiary of Rothschild & Co Continuation Limited ("R&CoCL"). The principal activity of the Company is the raising of finance for the purpose of lending it to companies who are members of the Rothschild Concordia SAS group. In the period ended 30 June 2023, £125,000,000 perpetual subordinated guaranteed notes were in issue by the Company. 

 

Risks and Uncertainties

 

The principal risks of the Company are credit risk, liquidity risk and market risk.  The Company follows the risk management policies of fellow subsidiary undertaking, N. M. Rothschild & Sons Limited ("NMR"). 

 

The Company's principal risk is credit exposure to other group companies, as the notes issued by the Company have been on-lent to R&CoCL and NMR. R&CoCL has guaranteed, on a subordinated basis, the notes issued. The Company's ability to meet its obligations in respect of notes issued by it is therefore reliant on NMR and R&CoCL to make payments to the Company. Both R&CoCL and NMR are exposed to current market and geopolitical headwinds but, nevertheless, have sufficient liquidity to continue to operate for the next 12 months even in the scenario where revenue is significantly reduced. Management has considered the going concern basis of preparation as outlined in note 1 to the financial statements.

 

This half-yearly financial report has not been audited or reviewed by the Company's auditors pursuant to the Auditing Practices Board guidance on Review of Interim Financial Information. 

 

Responsibility Statement  

 

The Directors confirm that to the best of their knowledge:

 

-

-

 

By Order of the Board

 

Peter Barbour

Director

04/09/2023

 

 

Condensed Interim Statement of Comprehensive Income

For the six months ended 30 June 2023

 



6 months to

6 months to



30 June
2023

30 June
2022


Note

£

£

Interest income


5,588,452

5,588,452

Interest expense


(5,578,767)

(5,578,767)

Operating profit

 

9,685

9,685

Revaluation of loans

4

(1,395,000)

(8,238,750)

Revaluations of debt securities

9

1,395,000

8,238,750

Administrative expenses


(650)

(650)

Profit before tax

 

9,035

9,035

Income tax expense

3

(1,988)

(1,717)

Profit for the financial period

 

7,047

7,318

Other comprehensive income


-

-

Total comprehensive income for the financial period

 

7,047

7,318

 

Condensed Interim Statement of Changes in Equity

For the six months ended 30 June 2023

 


 

Share Capital

Retained Earnings

 

Total


£

£

£

At 1 January 2023

100,000

203,986

303,986

Total comprehensive income for the period

-

7,047

7,047

At 30 June 2023

100,000

211,033

311,033





At 1 January 2022

100,000

188,692

288,692

Total comprehensive income for the period

-

7,318

7,318

At 30 June 2022

100,000

196,010

296,010

 

 

Condensed Interim Balance Sheet

At 30 June 2023

 



             At 30 June

             At 31 December



2023

2023

2022

2022


Note

£

£

£

£

Non-current assets






Loans to group undertakings

4


127,807,500


129,202,500

Current assets






Other financial assets

5

4,168,182


6,496,190


Cash and cash equivalents

6

208,135


3,542,325


 

 

4,376,317

 

10,038,515

 

Current liabilities






Current tax payable


(5,575)


(3,587)


Deferred tax

7

(23,750)


(23,750)


Other financial liabilities

8

(4,160,959)


(9,832,192)


Net current assets

 

 

186,033

 

178,986

Total assets less current liabilities

 

 

 

127,993,533

 

 

129,381,486

Non-current liabilities






Subordinated guaranteed notes

9


(127,682,500)


(129,077,500)

Net assets

 

 

311,033

 

303,986

Shareholders' equity






Share capital

11


100,000


100,000

Retained earnings



211,033


203,986

Total shareholders' equity

 

 

311,033

 

303,986

 

 

 

Condensed Interim Cash Flow Statement

For the six months ended 30 June 2023

 



6 months to

6 months to



30 June 2023

30 June 2022


Note

£

£

Cash flow from operating activities




Profit for the financial period


7,047

7,318

Income tax expenses


1,988

1,717

Net cash inflow from operating activities


9,035

9,035

 

Cash flow from financing activities

Fair value movements of loans


(1,395,000)

 

 

  (8,238,750)

Fair value movements of debt securities


1,395,000

8,238,750

Net decrease in other financial assets


2,328,008

2,328,008

Net decrease in other financial liabilities


(5,671,233)

(5,671,233)

Net cash outflow from financing activities


(3,343,225)

(3,343,225)

 

Net decrease in cash and cash equivalents


 

(3,334,190)

 

(3,334,190)

Cash and cash equivalents at beginning of the half-year


3,542,325

3,527,021

Cash and cash equivalents at end of the half-year

6

208,135

192,831

 

Interest paid and received during the period were as follows:

 


6 months to

6 months to


30 June 2023

30 June 2022


£

£

Interest paid

11,250,000

11,250,000

Interest received

7,916,460

7,916,460

 

The notes to the condensed interim financial statements form an integral part of the condensed interim financial statements. 

 

Notes to the Condensed Interim Financial Statements

(forming part of the Condensed Interim Financial Statements)

For the six months ended 30 June 2023

 

1.  Basis of preparation

 

The condensed interim financial statements are prepared and approved by the Directors in accordance with IAS 34 Interim Financial Reporting.  The condensed interim financial statements are prepared under the historical cost accounting rules and should be read in conjunction with the annual financial statements for the year ended 31 December 2022, which have been prepared in accordance with International Financial Reporting Standards. 

 

The accounting policies and methods of valuation are identical to those applied in the financial statements for the year ended 31 December 2022.

 

Going Concern

Management has performed an assessment to determine whether there are any material uncertainties that could cast significant doubt on the ability of the Company to continue as a going concern. No significant issues have been noted. In reaching this conclusion, management considered:

 

-

The financial impact of the uncertainty on the Company's balance sheet;

 

-

The Company's liquidity position based on current and projected cash resources.  The liquidity position has been assessed taking into account the forecast liquidity of NMR and R&CoCL and their ability to continue to pay the interest on the intercompany loan provided by the Company.

 

Based on the above assessment of the Company's financial position, the Directors have concluded that the Company has adequate resources to continue in operational existence for the foreseeable future (for a period of at least twelve months after the date that the financial statements are signed). Accordingly, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

 

Financial Risk Management

The Company follows the financial risk management policies of the parent undertaking, NMR.  The key risks arising from the Company's activities involving financial instruments, which are monitored at the group level, are as follows:

 

-

-

-

 

2.  Directors' Emoluments

 

None of the Directors received any remuneration in respect of their services to the Company during the period (2020: £nil). 

 

3.  Taxation

 


6 months to

6 months to


30 June 2023

30 June 2022


£

£

Current tax

(1,988)

(1,717)

Tax charged for the period

(1,988)

(1,717)

 

The current tax charge can be explained as follows:


6 months to

6 months to


30 June 2023

30 June 2022


£

£

Profit before tax

9,035

9,035

United Kingdom corporation tax charge at effective rate 22% (2022: 19%)

(1,988)

(1,717)

Tax charged for the period

(1,988)

(1,717)

 

4.  Non-Current Assets: Loans to Group Undertakings

 


At 30 June

At 31 December


2023

2022


£

£

At beginning of period

129,202,500

145,628,750

Fair value movements

(1,395,000)

(16,426,250)

At end of period

127,807,500

129,202,500

Due In 5 years or more

127,807,500

129,202,500

 

IFRS 9 requires the £125,000,000 loans to be carried at fair value which as at 30 June 2023 was £127,807,500 (at 31 December 2022: £129,202,500).  On an amortised cost basis, the value of the loan at 30 June 2023 would be £125,000,000 (at 31 December 2022: £125,000,000). The fair values are based on the market value of the external debt securities (level 2). 

 

The interest rate charged on the subordinated perpetual loans to group undertakings is 9 1/64 percent.

 

 

5.  Other Financial Assets


At 30 June

At 31 December


2023

2022


£

£

Amounts owed by parent undertaking

2,500,910

3,939,705

Amounts owed by fellow subsidiary undertaking

1,667,272

2,556,485


4,168,182

6,496,190

 

6.  Cash and Cash Equivalents

 

At 30 June 2023 the Company held cash of £208,135 (31 December 2022: £3,542,325) at a fellow subsidiary undertaking.

 

7.  Deferred Income Taxes

 


At 30 June

At 31 December


2023

2022


£

£

At beginning of period

(23,750)

(23,750)

At end of period

(23,750)

(23,750)

 

 

Deferred tax assets less liabilities are attributable to the following items:

 


At 30 June

2023

At 31 December

2022


£

£

Fair value of intra-group loans

(533,425)

(798,475)

Fair value of debt securities in issue

509,675

774,725

 

(23,750)

(23,750)


Both the intra-group loans and debt securities in issue are taxed on an amortised cost basis of accounting and accordingly taxable/deductible temporary differences arise following the adoption of IFRS 9.

 

8.   Other Financial Liabilities


At 30 June

At 31 December


2023

2022


£

£

Interest payable

4,160,959

9,832,192

 

Interest is payable on the subordinated guaranteed notes at 9 percent. 

 

 

9.  Subordinated Guaranteed Notes


At 30 June

At 31 December


2023

2022


£

£

At beginning of period

129,077,500

145,503,750

Fair value movements

(1,395,000)

(16,426,250)

At end of period

127,682,500

129,077,500

Due In 5 years or more

127,682,500

129,077,500

 

Given the IFRS 9 requirement to fair value the related loans, the Company has elected to fair value the subordinated guaranteed notes, which as at 30 June 2023 was £127,682,500 (at 31 December 2022: £129,077,500).  On an amortised cost basis, the value of the subordinated guaranteed notes at 30 June 2023 would be £125,000,000 (at 31 December 2022: £125,000,000). Consistent with the prior period, the fair value was derived from quoted market prices at the balance sheet date. In accordance with IFRS 13 and due to a

reduction in the frequency and volume of transactions observed in the immediate run up to the period

end, the fair value is considered to be level 2 as at 30 June 2023 (2022: level 1).

 

10.            Maturity of Financial Liabilities

 

The following table shows contractual cash flows payable by the Company on the subordinated guaranteed notes classified by remaining contractual maturity at the balance sheet date.  Interest cash flows on the loan notes are shown up to five years only, with the principal balance being shown in the >5 yr column.

 

At 30 June 2023

 

 

Demand

Demand - 3mth

3mth - 1yr

1yr - 5yr

>5 yr

Total


£

£

£

£

£

£

Loan notes in issue

 

-

 

 -

 

11,250,000

 

45,000,000

 

125,000,000

 

181,250,000

 

At 30 June 2022

 


Demand

Demand - 3mth

3mth - 1yr

1yr - 5yr

>5 yr

Total


£

£

£

£

£

£

Loan notes in issue

 

-

 

 -

 

11,250,000

 

45,000,000

 

125,000,000

 

181,250,000

 

11. Share Capital


At 30 June

At 31 December


2023

2022


£

£

Allotted, called up and fully paid



Ordinary shares of £1 each

100,000

100,000

 

12.            Related Party Transactions

 

Parties are considered to be related if one party controls, is controlled by or has the ability to exercise significant influence over the other party. This includes key management personnel, the parent company and fellow subsidiaries. 

 

Amounts recognised in respect of related parties at the period end were as follows:


 At 30 June

2023

At 31 December

2022


£

£

Subordinated perpetual loan to parent undertaking - fair value

51,123,000

51,681,000

Subordinated perpetual loan to fellow subsidiary undertaking - fair value

76,684,500

77,521,500

Amounts owed by parent undertaking

2,500,910

3,939,705

Amounts owed by fellow subsidiary undertaking

1,667,272

2,556,485

Cash at fellow subsidiary undertaking

208,135

3,542,325

 

Amounts recognised in the statement of comprehensive income in respect of related party transactions were as follows:


6 months to

30 June

2023

6 months to

30 June
2022


£

£

Interest receivable from parent undertaking

3,353,071

3,353,071

Interest receivable from fellow subsidiary undertaking

2,235,381

2,235,381

There were no loans made to Directors during the period (6 months to 30 June 2022: none) and no balances outstanding at the period end (at 31 December 2022: £nil).  There were no employees of the Company during the period (6 months to 30 June 2022: none).

13. Parent Undertaking and Ultimate Holding Company and Registered Office

The largest group in which the results of the Company are consolidated is that headed by Rothschild & Co Concordia SAS, incorporated in France. The smallest group in which they are consolidated is that headed by Rothschild & Co SCA, a French public limited partnership, whose registered office is also at 23bis, Avenue de Messine, 75008 Paris.  The accounts are available on the Rothschild & Co website at

The Company's immediate parent company is Rothschild & Co Continuation Limited, incorporated in England and Wales and whose registered office is at New Court, St Swithins Lane, London, EC4N 8AL.

The Company's registered office is located at St Julian's Court, St Peter Port, Guernsey, GY1 3BP.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings